Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8232516 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 7 Pages |
Abstract
In men with localized PCa who have no or mild comorbidity, adding 6 months of AST to RT was associated with improved survival for those with both intermediate-risk and high-risk disease, but in men with moderate to severe comorbidity, no benefit was observed in either risk group.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Paul L. M.D., Ming-Hui Ph.D., Clair J. M.D., W. Warren M.D., M.P.H., Andrew A. M.D., Marian R.N., B.S., O.C.N., Elizabeth R.N., B.S.N., Philip W. M.D., Anthony V. M.D., Ph.D.,